BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34572755)

  • 1. Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion.
    Lavoie RR; Gargollo PC; Ahmed ME; Kim Y; Baer E; Phelps DA; Charlesworth CM; Madden BJ; Wang L; Houghton PJ; Cheville J; Dong H; Granberg CF; Lucien F
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma.
    Timpanaro A; Piccand C; Uldry AC; Bode PK; Dzhumashev D; Sala R; Heller M; Rössler J; Bernasconi M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
    Waschbisch A; Wintterle S; Lochmüller H; Walter MC; Wischhusen J; Kieseier BC; Wiendl H
    Arthritis Rheum; 2008 Nov; 58(11):3600-8. PubMed ID: 18975328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
    Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
    Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
    [No Abstract]   [Full Text] [Related]  

  • 5. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
    Majzner RG; Theruvath JL; Nellan A; Heitzeneder S; Cui Y; Mount CW; Rietberg SP; Linde MH; Xu P; Rota C; Sotillo E; Labanieh L; Lee DW; Orentas RJ; Dimitrov DS; Zhu Z; Croix BS; Delaidelli A; Sekunova A; Bonvini E; Mitra SS; Quezado MM; Majeti R; Monje M; Sorensen PHB; Maris JM; Mackall CL
    Clin Cancer Res; 2019 Apr; 25(8):2560-2574. PubMed ID: 30655315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma.
    Zheng M; Yu L; Hu J; Zhang Z; Wang H; Lu D; Tang X; Huang J; Zhong K; Wang Z; Li Y; Guo G; Liu S; Tong A; Yang H
    Transl Oncol; 2020 May; 13(5):100770. PubMed ID: 32298986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response.
    Chen C; Shen Y; Qu QX; Chen XQ; Zhang XG; Huang JA
    Exp Cell Res; 2013 Jan; 319(1):96-102. PubMed ID: 22999863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
    Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
    Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma.
    Mao Y; Chen L; Wang F; Zhu D; Ge X; Hua D; Sun J
    Oncol Lett; 2017 Nov; 14(5):6177-6183. PubMed ID: 29113264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors.
    Rasic P; Jovanovic-Tucovic M; Jeremic M; Djuricic SM; Vasiljevic ZV; Milickovic M; Savic D
    World J Gastrointest Oncol; 2021 Aug; 13(8):799-821. PubMed ID: 34457187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.
    Lee YH; Martin-Orozco N; Zheng P; Li J; Zhang P; Tan H; Park HJ; Jeong M; Chang SH; Kim BS; Xiong W; Zang W; Guo L; Liu Y; Dong ZJ; Overwijk WW; Hwu P; Yi Q; Kwak L; Yang Z; Mak TW; Li W; Radvanyi LG; Ni L; Liu D; Dong C
    Cell Res; 2017 Aug; 27(8):1034-1045. PubMed ID: 28685773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
    Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
    Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
    Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 role in the immune landscape of cancer.
    Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
    Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma.
    Zhang C; Zhang Z; Li F; Shen Z; Qiao Y; Li L; Liu S; Song M; Zhao X; Ren F; He Q; Yang B; Fan R; Zhang Y
    Oncoimmunology; 2018; 7(11):e1461304. PubMed ID: 30377558
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoforms of human B7-H3 co-signalling molecule for T cell activation as potential immunoregulatory agents.
    Expert Opin Ther Pat; 2005 Jun; 15(6):745-9. PubMed ID: 20141505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.
    Al-Sukaini A; Hornicek FJ; Peacock ZS; Kaban LB; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2017 Dec; 475(12):3071-3081. PubMed ID: 28725958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.